Showing results (671-680 of 740) with videos related to

Sort By:
Pageof 74
Archives of Toxicology|May 16, 2018
Omics-based responses induced by bosentan in human hepatoma HepaRG cell culturesRobim M Rodrigues, Laxmikanth Kollipara, Umesh Chaudhari, et al.
Transplantation|May 9, 2009
Acute liver transplant rejection upon immunosuppression withdrawal in a tolerance induction trial: potential role of IFN-gamma-secreting CD8+ T cellsVincent Donckier, Ligia Craciun, Valerio Lucidi, et al.
Hepatology (Baltimore, Md.)|September 29, 2011
Successful isolation of liver progenitor cells by aldehyde dehydrogenase activity in naïve miceLaurent Dollé, Jan Best, Christophe Empsen, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2021
Patient-reported outcomes for monitoring symptomatic toxicities in cancer patients treated with immune-checkpoint inhibitors: A Delphi studyAndré Manuel Da Silva Lopes, Sara Colomer-Lahiguera, Nuria Mederos Alfonso, et al.
Annals of Surgery|August 7, 2018
Left-liver Adult-to-Adult Living Donor Liver Transplantation: Can It Be Improved? A Retrospective Multicenter European StudySantiago Sánchez-Cabús, Daniel Cherqui, Niki Rashidian, et al.
Canadian Journal of Gastroenterology & Hepatology|April 6, 2019
Accuracy of Pretransplant Imaging Diagnostic for Hepatocellular Carcinoma: A Retrospective German Multicenter StudyUta Herden, Wenzel Schoening, Johann Pratschke, et al.
The Journal of Experimental Medicine|February 9, 2005
RAGE limits regeneration after massive liver injury by coordinated suppression of TNF-alpha and NF-kappaBGuellue Cataldegirmen, Shan Zeng, Nikki Feirt, et al.
EXCLI Journal|September 30, 2015
Testing chemical carcinogenicity by using a transcriptomics HepaRG-based model?T Y Doktorova, Reha Yildirimman, Liesbeth Ceelen, et al.
Nature Communications|November 16, 2018
Sustained activation of the Aryl hydrocarbon Receptor transcription factor promotes resistance to BRAF-inhibitors in melanomaSébastien Corre, Nina Tardif, Nicolas Mouchet, et al.
Regulatory Toxicology and Pharmacology : RTP|August 28, 2023
Exposure considerations in human safety assessment: Report from an EPAA Partners' ForumMark T D Cronin, Nicholas Ball, Sonja Beken, et al.
Pageof 74